U.S. Markets open in 38 mins

Scotts Miracle-Gro is the Real Cannabis Investment

When I checked at The MoneyShow Las Vegas this morning one of the first things I did was stop in at the The Cannabis Investing Event to see what all the buzz was about. I have a full schedule of my own over the next few days of the show, but I like to do a little reconnaissance to see if I can unearth and attractive opportunities.

There were other interesting “pre-show” tracks on options, ETFs and stock picking. As I made the rounds and ventured into the cannabis track room I felt today was good moment to remind folks of our pick nearly two years ago of the most solid cannabis stock play out there: Scotts Miracle-Gro (SMG).

Scotts came through our rigorous stock screen in October 2015 as an attractive undervalued, growing, materials stock in our seasonal stock-buying sweet spot at the outset of the Best Six Months. But in reality the big move in SMG over the past few years has been stimulated by the heavy usage of Scotts Miracle-Gro products by cannabis growers.

Here at the event there are a host of cannabis stocks that I have not analyzed yet. While some business models sound viable, I am dubious any will pass muster, but here is the list of cannabis stocks here at MoneyShow Las Vegas that are public. All are thinly traded, early stage and have little revenue or earnings if any at all. But here you go if you want to kick the tires. I am by no means suggesting anyone buy any of these stocks. Just FYI.

Aurora Cannabis Inc. (ACBFF)
Canabo Medical Inc. (CMM.V)
Lexaria Bioscience Corp. (LXRP)
MassRoots (MSRT)
THC Therapeutics, Inc. (THCT)
Vitality Biopharma, Inc. (VBIO)

However, SMG is real company with real liquidity, revenue, earnings and growth. When we first brought SMG to our subscribers attention in October 2015 the stock was trading around 65.48. Our original buy limit below the market was not initially reached, but eventually in December 2015 it was added to our portfolio at our higher buy limit of 66.75. SMG recently traded over 98, but has been retreating of late and is currently setting up for another buy opportunity. But we remain patient. SMG is in our Almanac Investor Newsletter Portfolio on HOLD. We may buy more maybe at the seasonal summer low. Stay cool…